Friday, November 4, 2022
CAR T-cell therapy is quickly becoming one of the most talked about new treatments in the field of oncology, but who might be an appropriate patient for this type of therapy? In this session we will talk about what CAR T-cell therapy is, how it works, some of the potential risks and benefits, as well as some considerations around eligibility and access. Attendees will leave this session with a greater understanding of CAR T-cell therapy.
Grief is all-encompassing. Balancing your mental health and the logistics of loss are daunting tasks. In this session, we’ll discuss ways to navigate the grief and the end of life processes. Through this dialogue, you will learn how to prioritize your self-care and understand the tasks ahead so that you can lean into the strength of your community.
How does food correlate with cancer? In this session we will talk about nutrition, the myths and fear mongering surrounding food and cancer, and explore tools for nourishing our bodies in a way that feels right for our individual needs.
How do we create space for discussion on the barriers that come with caregiving as someone in the African American/Black community and the systemic change that needs to happen for better outcomes after a loved one’s diagnosis? In this session, a panel of caregivers and providers will facilitate a conversation to explore the needs of African American/Black Cancer Caregivers and identify the financial and emotional gaps in support. Come share your experience and meet peers as we discuss these pressing issues and the solutions for change that are long overdue. *Note: This meeting will be recorded. Participants can engage with the session as much as they are comfortable, i.e. turning on their video and/or unmuting themselves to speak.
Hear voices from a Roundtable convened by Takeda and Gryt Health this past year. Trust and empathy plays a huge and important role in creating a welcoming environment for people interacting with the healthcare ecosystem. In this session, we will focus on communication and navigation, biomarker testing, and stigma from people with lived experiences in lung cancer. Together we will leave this session with a better understanding of the barriers that prevent communities who have been historically marginalized from receiving optimal health outcomes when living with lung cancer and solutions for change. Join us for this open dialogue and to share your experience with peers. *NSCLC: Non-Small Cell Lung Cancer *Note: This meeting will be recorded. Participants can engage with the session as much as they are comfortable, i.e. turning on their video and/or unmuting themselves to speak.